Tags

Type your tag names separated by a space and hit enter

Overview of the 3rd isirv-Antiviral Group Conference--advances in clinical management.
Influenza Other Respir Viruses. 2015 Jan; 9(1):20-31.IO

Abstract

This review highlights the main points which emerged from the presentations and discussions at the 3rd isirv-Antiviral Group Conference - advances in clinical management. The conference covered emerging and potentially pandemic influenza viruses and discussed novel/pre-licensure therapeutics and currently approved antivirals and vaccines for the control of influenza. Current data on approved and novel treatments for non-influenza respiratory viruses such as MERS-CoV, respiratory syncytial virus (RSV) and rhinoviruses and the challenges of treating immunocompromised patients with respiratory infections was highlighted.

Links

Publisher Full Text
ncbi.nlm.nih.gov
doi.org
PMC Free PDF
Aggregator Full Text

Authors+Show Affiliations

Hurt AC
WHO Collaborating Centre for Reference and Research on Influenza, VIDRL at the Peter Doherty Institute for Infection and Immunity, Parkville, Vic., Australia; Melbourne School of Population and Global Health, University of Melbourne, Parkville, Vic., Australia.
Hui DS
No affiliation info available
Hay A
No affiliation info available
Hayden FG
No affiliation info available

MeSH

Antiviral AgentsCommunicable Diseases, EmergingCoronavirus InfectionsHumansImmunocompromised HostInfluenza VaccinesInfluenza, HumanMiddle East Respiratory Syndrome CoronavirusPandemicsRespiratory Syncytial Virus InfectionsRespiratory Tract InfectionsVirus Diseases

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't
Review

Language

eng

PubMed ID

25399715

Citation

Hurt, Aeron C., et al. "Overview of the 3rd isirv-Antiviral Group Conference--advances in Clinical Management." Influenza and Other Respiratory Viruses, vol. 9, no. 1, 2015, pp. 20-31.
Hurt AC, Hui DS, Hay A, et al. Overview of the 3rd isirv-Antiviral Group Conference--advances in clinical management. Influenza Other Respir Viruses. 2015;9(1):20-31.
Hurt, A. C., Hui, D. S., Hay, A., & Hayden, F. G. (2015). Overview of the 3rd isirv-Antiviral Group Conference--advances in clinical management. Influenza and Other Respiratory Viruses, 9(1), 20-31. https://doi.org/10.1111/irv.12293
Hurt AC, et al. Overview of the 3rd isirv-Antiviral Group Conference--advances in Clinical Management. Influenza Other Respir Viruses. 2015;9(1):20-31. PubMed PMID: 25399715.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Overview of the 3rd isirv-Antiviral Group Conference--advances in clinical management. AU - Hurt,Aeron C, AU - Hui,David S, AU - Hay,Alan, AU - Hayden,Frederick G, Y1 - 2014/11/15/ PY - 2014/10/14/accepted PY - 2014/11/18/entrez PY - 2014/11/18/pubmed PY - 2015/8/5/medline KW - Antivirals KW - clinical management KW - immunocompromised KW - influenza KW - respiratory KW - treatment SP - 20 EP - 31 JF - Influenza and other respiratory viruses JO - Influenza Other Respir Viruses VL - 9 IS - 1 N2 - This review highlights the main points which emerged from the presentations and discussions at the 3rd isirv-Antiviral Group Conference - advances in clinical management. The conference covered emerging and potentially pandemic influenza viruses and discussed novel/pre-licensure therapeutics and currently approved antivirals and vaccines for the control of influenza. Current data on approved and novel treatments for non-influenza respiratory viruses such as MERS-CoV, respiratory syncytial virus (RSV) and rhinoviruses and the challenges of treating immunocompromised patients with respiratory infections was highlighted. SN - 1750-2659 UR - https://www.unboundmedicine.com/medline/citation/25399715/Overview_of_the_3rd_isirv_Antiviral_Group_Conference__advances_in_clinical_management_ L2 - https://doi.org/10.1111/irv.12293 DB - PRIME DP - Unbound Medicine ER -